Stock Market Symbols
GIB.A (TSX)
GIB (NYSE)
cgi.com/newsroom
MONTRÉAL, July 13, 2021 /CNW
Telbec/ - CGI (TSX: GIB.A) (NYSE: GIB) signed a full managed
IT services contract with the international life sciences firm
Nexelis. Through the agreement, Nexelis will leverage CGI's global
scale, best practices in IT modernization, and approach to
accelerate business transformation.
Following the successful launch of a managed security services
platform, CGI developed a three-year IT strategy to support
Nexelis' rapid growth. This IT transformation roadmap includes the
delivery of full managed services for the company's core IT
infrastructure and a portfolio of enterprise applications. Nexelis'
first transformation priorities are the upgrade and international
rollout of Infrastructure Managed Services (IMS) and a Laboratory
Information Management System (LIMS).
"We believe that success in our field is best achieved by a
fusion of scientific discipline, human agility and client
partnership," said Benoit Bouche,
Nexelis CEO. "CGI's proven and comprehensive managed IT services
will allow us to focus on science, which is what we do best, while
giving us a competitive advantage through the advancement of our IT
modernization and the digitization of our business and IT
workflows."
"As Nexelis' trusted advisor and partner of choice, CGI brings
years of in-the-field experience in managing both security and core
business processes in life sciences and other sectors," said
Guy Vigeant, President of CGI's
operations in Canada. "We look
forward to helping Nexelis build a more secure IT infrastructure as
well as a solid portfolio of enterprise applications to drive its
business agility, performance and growth."
About CGI
Founded in 1976, CGI is among the largest
independent IT and business consulting services firms in the world.
With 77,000 consultants and other professionals across the globe,
CGI delivers an end-to-end portfolio of capabilities, from
strategic IT and business consulting to systems integration,
managed IT and business process services and intellectual property
solutions. CGI works with clients through a local relationship
model complemented by a global delivery network that helps clients
digitally transform their organizations and accelerate results. CGI
Fiscal 2020 reported revenue is C$12.16
billion and CGI shares are listed on the TSX (GIB.A) and the
NYSE (GIB). Learn more at cgi.com.
About Nexelis
With an unrivaled expertise in
immunology, 5 operating sites in North
America and Europe, and a
translational offer of services covering the needs of the
pharmaceutical industry from the lead selection stage to late
clinical stage, Nexelis is a leading provider of assay development
and advanced laboratory testing services in the infectious
diseases, metabolic diseases, and oncology fields. Our versatile
team of scientists, working with our state-of-the-art technology
platforms, were instrumental in the development, qualification,
validation, and large-scale sample testing of assays that supported
the FDA filing of almost 100 new molecular entities, including
blockbuster vaccines and biologics, anti-viral drugs,
immunotherapy, gene and cell therapy products.
View original
content:https://www.prnewswire.com/news-releases/cgi-helps-nexelis-gain-a-competitive-advantage-through-digitization-of-business-and-it-workflows-301332126.html
SOURCE CGI Inc.